Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Scandinavian pharmaceuticals market had total revenues of $17.1 billion in 2022, representing a compound annual growth rate (CAGR) of 3.4% between 2017 and 2022.
- 0
- Sweden acquired a 38% share of the Scandinavian pharmaceuticals market in 2022. The Nordics are a significant hub for pharmaceutical innovation and production, with Finland having one of Europe's fastest-aging populations. With over 23% of people aged 65 or over, the region has a high life expectancy at birth. Lifestyle-related diseases like diabetes and obesity are driving growth in the pharmaceutical markets, particularly cardiovascular ones.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Scandinavia pharmaceuticals market by value in 2022?
- What will be the size of the Scandinavia pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Scandinavia's pharmaceuticals market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novartis AG
- Sanofi SA
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd